Capricor Therapeutics, Inc.CAPRNASDAQ
Loading
Year-over-year net income growth rate
Percentile
P23
Within normal range
vs 2Y Ago
-0.3x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -22.79% |
| Q3 2025 | 5.17% |
| Q2 2025 | -6.23% |
| Q1 2025 | -242.74% |
| Q4 2024 | 43.32% |
| Q3 2024 | -14.15% |
| Q2 2024 | -12.31% |
| Q1 2024 | -1185.16% |
| Q4 2023 | 88.07% |
| Q3 2023 | 13.25% |
| Q2 2023 | 5.17% |
| Q1 2023 | -0.61% |
| Q4 2022 | -21.19% |
| Q3 2022 | 10.38% |
| Q2 2022 | 9.06% |
| Q1 2022 | -26.29% |
| Q4 2021 | -57.45% |
| Q3 2021 | 17.19% |
| Q2 2021 | 7.84% |
| Q1 2021 | -23.31% |
| Q4 2020 | -6.85% |
| Q3 2020 | -12.23% |
| Q2 2020 | -67.12% |
| Q1 2020 | -41.88% |
| Q4 2019 | 8.56% |
| Q3 2019 | 21.46% |
| Q2 2019 | 18.78% |
| Q1 2019 | 22.73% |
| Q4 2018 | 21.18% |
| Q3 2018 | -0.29% |
| Q2 2018 | -12.31% |
| Q1 2018 | -129.84% |
| Q4 2017 | 549.91% |
| Q3 2017 | 21.23% |
| Q2 2017 | 5.32% |
| Q1 2017 | 18.84% |
| Q4 2016 | 15.28% |
| Q3 2016 | -13.73% |
| Q2 2016 | -9.92% |
| Q1 2016 | -27.50% |